FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029520696> ?p ?o ?g. }

• W3029520696 abstract "e19040 Background: Aggressive BCL is curable but previous studies have shown that minorities have inferior survival, partly due to socioeconomic barriers and poor access to care. NN programs are designed to reduce barriers to care via various methods. We present disease characteristics, treatment, and outcomes of Caucasian (C) & non-Caucasian (NC) pts with aggressive BCL at Levine Cancer Institute which has an active NN program. Methods: We collected demographic, insurance, disease characteristics, treatment, and outcomes for pts with aggressive BCL [diffuse large B cell lymphoma (DLBCL), primary mediastinal B cell lymphoma (PMBCL), or high grade B cell lymphoma (HGL)] between Jan 2016 and Jun 2019. Race (C or NC) was self-reported. NN encounters were characterized as low intensity (basic needs) or high (moderate/high needs). OS and PFS were calculated using Kaplan Meier. Demographics were compared using Fisher's Exact tests. Results: 204 pts (186 = DLBCL, 14 = PMBCL, 4 = HGL) were included (NC = 47; C = 157). NC were younger at diagnosis (median age 56 vs 62 yrs, p = 0.03) and more likely to be uninsured/Medicaid (26% vs 4%, p < 0.0001). There were no significant differences in prognostic scores (44% vs 50% R-IPI score 3-5, p = 0.5), incidence of double hit (11% vs 13%, p = 0.8), frontline rituximab/anthracycline containing chemotherapy (98% vs 96%, p = 0.9), and incidence of relapsed/refractory (R/R) disease (40% vs 37%, p = 0.7) for NC compared to C. For R/R BCL, similar % of pts underwent hematopoietic stem cell transplant (SCT) (32% NC vs 28% C, p = 0.8) or CAR-T cell therapy (16% NC vs 19% C, p = 0.9). Enrollment in clinical trials was comparable (17% NC vs 14% C, p = 0.6). The % of pts receiving NN was similar (81% NC, 87% C, p = 0.4) but NC had higher intensity NN encounters (42% vs 21%, p = 0.01). With median follow up of 35 mo, OS and PFS were comparable between both groups. The 2 yr OS was 81% for NC and 76% for C, p = 0.3; 2 yr PFS was 62% for NC and 64% for C, p = 0.8. Conclusions: We show equivalent survival between Caucasian and non-Caucasian pts with aggressive BCL. Disease biology and treatment patterns--including access to SCT, CAR-T and clinical trials--were similar in both groups. Differences in insurance coverage favored Caucasians. Similar proportion of pts in both groups received nurse navigation, but non-Caucasian pts had higher intensity navigation needs. Providing equal access to care and availability of an active nurse navigation program may overcome racial heath disparities. This study has implications for national health policy." @default.
• W3029520696 created "2020-06-05" @default.
• W3029520696 creator A5018065917 @default.
• W3029520696 creator A5020852034 @default.
• W3029520696 creator A5027193786 @default.
• W3029520696 creator A5035890812 @default.
• W3029520696 creator A5047723343 @default.
• W3029520696 creator A5052543736 @default.
• W3029520696 creator A5055990171 @default.
• W3029520696 creator A5059317772 @default.
• W3029520696 creator A5059850025 @default.
• W3029520696 creator A5066072212 @default.
• W3029520696 creator A5069014112 @default.
• W3029520696 creator A5074766331 @default.
• W3029520696 creator A5078207811 @default.
• W3029520696 creator A5087862515 @default.
• W3029520696 creator A5088351219 @default.
• W3029520696 date "2020-05-20" @default.
• W3029520696 modified "2023-09-23" @default.
• W3029520696 title "Outcomes in minority patients (pt) with aggressive B cell lymphoma (BCL) if optimally managed with equal access to care and nurse navigation (NN)." @default.
• W3029520696 doi "https://doi.org/10.1200/jco.2020.38.15_suppl.e19040" @default.
• W3029520696 hasPublicationYear "2020" @default.
• W3029520696 type Work @default.
• W3029520696 sameAs 3029520696 @default.
• W3029520696 citedByCount "0" @default.
• W3029520696 crossrefType "journal-article" @default.
• W3029520696 hasAuthorship W3029520696A5018065917 @default.
• W3029520696 hasAuthorship W3029520696A5020852034 @default.
• W3029520696 hasAuthorship W3029520696A5027193786 @default.
• W3029520696 hasAuthorship W3029520696A5035890812 @default.
• W3029520696 hasAuthorship W3029520696A5047723343 @default.
• W3029520696 hasAuthorship W3029520696A5052543736 @default.
• W3029520696 hasAuthorship W3029520696A5055990171 @default.
• W3029520696 hasAuthorship W3029520696A5059317772 @default.
• W3029520696 hasAuthorship W3029520696A5059850025 @default.
• W3029520696 hasAuthorship W3029520696A5066072212 @default.
• W3029520696 hasAuthorship W3029520696A5069014112 @default.
• W3029520696 hasAuthorship W3029520696A5074766331 @default.
• W3029520696 hasAuthorship W3029520696A5078207811 @default.
• W3029520696 hasAuthorship W3029520696A5087862515 @default.
• W3029520696 hasAuthorship W3029520696A5088351219 @default.
• W3029520696 hasConcept C120665830 @default.
• W3029520696 hasConcept C121332964 @default.
• W3029520696 hasConcept C126322002 @default.
• W3029520696 hasConcept C143998085 @default.
• W3029520696 hasConcept C144024400 @default.
• W3029520696 hasConcept C149923435 @default.
• W3029520696 hasConcept C160735492 @default.
• W3029520696 hasConcept C162324750 @default.
• W3029520696 hasConcept C2776534028 @default.
• W3029520696 hasConcept C2778559949 @default.
• W3029520696 hasConcept C2779338263 @default.
• W3029520696 hasConcept C2780084366 @default.
• W3029520696 hasConcept C2780653079 @default.
• W3029520696 hasConcept C50522688 @default.
• W3029520696 hasConcept C61511704 @default.
• W3029520696 hasConcept C71924100 @default.
• W3029520696 hasConceptScore W3029520696C120665830 @default.
• W3029520696 hasConceptScore W3029520696C121332964 @default.
• W3029520696 hasConceptScore W3029520696C126322002 @default.
• W3029520696 hasConceptScore W3029520696C143998085 @default.
• W3029520696 hasConceptScore W3029520696C144024400 @default.
• W3029520696 hasConceptScore W3029520696C149923435 @default.
• W3029520696 hasConceptScore W3029520696C160735492 @default.
• W3029520696 hasConceptScore W3029520696C162324750 @default.
• W3029520696 hasConceptScore W3029520696C2776534028 @default.
• W3029520696 hasConceptScore W3029520696C2778559949 @default.
• W3029520696 hasConceptScore W3029520696C2779338263 @default.
• W3029520696 hasConceptScore W3029520696C2780084366 @default.
• W3029520696 hasConceptScore W3029520696C2780653079 @default.
• W3029520696 hasConceptScore W3029520696C50522688 @default.
• W3029520696 hasConceptScore W3029520696C61511704 @default.
• W3029520696 hasConceptScore W3029520696C71924100 @default.
• W3029520696 hasLocation W30295206961 @default.
• W3029520696 hasOpenAccess W3029520696 @default.
• W3029520696 hasPrimaryLocation W30295206961 @default.
• W3029520696 hasRelatedWork W11317782 @default.
• W3029520696 hasRelatedWork W12531894 @default.
• W3029520696 hasRelatedWork W1253675 @default.
• W3029520696 hasRelatedWork W16896924 @default.
• W3029520696 hasRelatedWork W18393754 @default.
• W3029520696 hasRelatedWork W7211030 @default.
• W3029520696 hasRelatedWork W8356937 @default.
• W3029520696 hasRelatedWork W13636764 @default.
• W3029520696 hasRelatedWork W21064296 @default.
• W3029520696 hasRelatedWork W3404728 @default.
• W3029520696 isParatext "false" @default.
• W3029520696 isRetracted "false" @default.
• W3029520696 magId "3029520696" @default.
• W3029520696 workType "article" @default.